metoprolol has been researched along with Polycystic Kidney, Autosomal Dominant in 2 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Polycystic Kidney, Autosomal Dominant: Kidney disorders with autosomal dominant inheritance and characterized by multiple CYSTS in both KIDNEYS with progressive deterioration of renal function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty-six hypertensive ADPKD patients were randomized to either ramipril (n = 23) or metoprolol (n = 23)." | 5.13 | Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease. ( Poliak, R; Schmieder, RE; Schulze, BD; Stiasny, B; Zeltner, R, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zeltner, R | 1 |
| Poliak, R | 1 |
| Stiasny, B | 1 |
| Schmieder, RE | 1 |
| Schulze, BD | 1 |
| Steinman, TI | 1 |
1 trial available for metoprolol and Polycystic Kidney, Autosomal Dominant
| Article | Year |
|---|---|
Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agent | 2008 |
1 other study available for metoprolol and Polycystic Kidney, Autosomal Dominant
| Article | Year |
|---|---|
Renal and cardiac effects of antihypertensive treatment with ramipril versus metoprolol in autosomal dominant polycystic kidney disease.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Hear | 2008 |